Yongxian Hu, Qian Tan, Jiqin Zhang, Mingming Zhang, Wenjun Wu, Guoqing Wei, Binghe Tan, Jiazhen Cui, Yuxuan Wu, Dali Li, Bing Du, Mingyao Liu, He Huang. "Long term remission and survival in patients with relapsed or refractory non-Hodgkin lymphoma after treatment of brl-201, a CRISPR-based non-viral PD-1 locus specifically integrated anti-CD19 CAR-T cells: 4-year follow-up of a first-in-human phase I study." Blood, 2025. doi:10.1182/blood-2025-5930